Chat IA

Balchem Corporation

BCPC · NasdaqGS · USD

166.83 +2.44 (1.48%)

Al cierre: Sep 14, 2026, 3:59 PM

166.83 +0.00%

Fuera de horario: 7:30 PM

Volumen
246K

Balchem Corporation (BCPC): cotización, análisis y datos

Valor intrínseco

Cargando valor intrínseco…

Pronóstico del analista

Previsiones bursátiles →

Precio objetivo

$165,00 – $242,00

mediana $215,00 · 28.87% Potencial alcista

Objetivo a 12 meses · 4 analistas

Consenso de analistas: n/a

Intervalo:1D
Cargando velas y señales…

Desempeño financiero

Ver finanzas →

Cargando...

Últimos resultados

ReportadoVs. estimaciónCambio interanual
Ingresosn/an/a
EPS$1,49+$0,06+17.32%

Próximos resultados

antes de que se abra el mercado.

Estimar · Actualizar →

Ver detalles de resultados →

Métricas

Precio de compra
118.31
Beneficio neto (TTM)
164M
0.81
5.08
32.84
26.6
P/B (TTM)
4.09
P/S (TTM)
4.90
Fecha de resultados
Oct 20, 2026
Precio de venta
212.8
Volumen
245,512
Volumen medio (20D)
212,590
Abierto
165.58
Anterior Cerrar
164.39
Rango del día
164.96 - 168.18
Rango de 52 semanas
139.17 - 183.90
Precio objetivo
215 (28.87%)
Dividendos
$0.96 (0.58%)
Fecha ex dividendo
Dec 23, 2025

Acerca de Balchem Corporation

Ver perfil →
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Specialty Chemicals · Basic Materials

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

IPO Fecha Jun 3, 1986
Empleados 1,379
Bolsa de Valores NasdaqGS
Símbolo bursátil BCPC